{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:22Z","timestamp":1787020222903,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the Beijing Science and Technology Committee","award":["D131100004713007"],"award-info":[{"award-number":["D131100004713007"]}]},{"name":"National Key Technology Research and Development Program of the Ministry of Science and Technology","award":["2011BAI10B01"],"award-info":[{"award-number":["2011BAI10B01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0441-9","type":"journal-article","created":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T07:45:12Z","timestamp":1484379912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE)"],"prefix":"10.1186","volume":"18","author":[{"name":"on behalf of the C-STRIDE study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Rong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Ping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,14]]},"reference":[{"issue":"9818","key":"441_CR1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815\u201322.","journal-title":"Lancet"},{"issue":"9","key":"441_CR2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/nep.12493","volume":"20","author":"S Iimori","year":"2015","unstructured":"Iimori S, Naito S, Noda Y, et al. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study. Nephrology (Carlton). 2015;20(9):601\u20138.","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"441_CR3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/j.ajkd.2015.01.021","volume":"66","author":"R Shah","year":"2015","unstructured":"Shah R, Matthews GJ, Shah RY, et al. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015;66(2):266\u201373.","journal-title":"Am J Kidney Dis"},{"key":"441_CR4","doi-asserted-by":"crossref","first-page":"597906","DOI":"10.1155\/2013\/597906","volume":"2013","author":"J Ritchie","year":"2013","unstructured":"Ritchie J, Rainone F, Green D, et al. Extreme Elevations in Blood Pressure and All-Cause Mortality in a Referred CKD Population: Results from the CRISIS Study. Int J Hypertens. 2013;2013:597906.","journal-title":"Int J Hypertens"},{"key":"441_CR5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2369-12-53","volume":"12","author":"A Martinez-Castelao","year":"2011","unstructured":"Martinez-Castelao A, Gorriz JL, Portoles JM, et al. Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study. BMC Nephrol. 2011;12:53.","journal-title":"BMC Nephrol"},{"key":"441_CR6","first-page":"e1","volume":"A7","author":"AJ Collins","year":"2012","unstructured":"Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;A7:e1\u2013420.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"441_CR7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00125-010-1854-1","volume":"54","author":"PL Drury","year":"2011","unstructured":"Drury PL, Ting R, Zannino D, et al. Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia. 2011;54(1):32\u201343.","journal-title":"Diabetologia"},{"issue":"11","key":"441_CR8","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3760\/cma.j.issn.0366-6999.20132906","volume":"127","author":"B Gao","year":"2014","unstructured":"Gao B, Zhang L, Wang H, Zhao M. Chinese cohort study of chronic kidney disease: design and methods. Chin Med J (Engl). 2014;127(11):2180\u20135.","journal-title":"Chin Med J (Engl)"},{"key":"441_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease: Improving GlobalOutcomes (KDIGO) CKD Work Group","year":"2013","unstructured":"Kidney Disease: Improving GlobalOutcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for theEvaluation and Management of Chronic Kidney Disease. Kidney inter. 2013;3:1\u2013150.","journal-title":"Kidney inter"},{"issue":"9","key":"441_CR10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"8","key":"441_CR11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","volume":"4","author":"JP Lash","year":"2009","unstructured":"Lash JP, Go AS, Appel LJ, et al. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009;4(8):1302\u201311.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"21","key":"441_CR12","first-page":"4787","volume":"57","author":"ML Le","year":"1997","unstructured":"Le ML, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res. 1997;57(21):4787\u201394.","journal-title":"Cancer Res"},{"issue":"12","key":"441_CR13","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1377\/hlthaff.2012.0535","volume":"31","author":"Z Feng","year":"2012","unstructured":"Feng Z, Liu C, Guan X, Mor V. China\u2019s rapidly aging population creates policy challenges in shaping a viable long-term care system. Health Aff (Millwood). 2012;31(12):2764\u201373.","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"441_CR14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehr205","volume":"33","author":"ZJ Yang","year":"2012","unstructured":"Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG, Yang WY. Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007\u20132008 China National Diabetes and Metabolic Disorders Study. Eur Heart J. 2012;33(2):213\u201320.","journal-title":"Eur Heart J"},{"issue":"11","key":"441_CR15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113263","volume":"9","author":"M Ohno","year":"2014","unstructured":"Ohno M, Deguchi F, Izumi K, et al. Correlation between renal function and common risk factors for chronic kidney disease in a healthy middle-aged population: a prospective observational 2-year study. PLoS ONE. 2014;9(11), e113263.","journal-title":"PLoS ONE"},{"issue":"2","key":"441_CR16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.ki.5002017","volume":"71","author":"K Yamagata","year":"2007","unstructured":"Yamagata K, Ishida K, Sairenchi T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71(2):159\u201366.","journal-title":"Kidney Int"},{"issue":"13","key":"441_CR17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296\u2013305.","journal-title":"N Engl J Med"},{"issue":"6","key":"441_CR18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1159\/000194455","volume":"29","author":"TP Ryan","year":"2009","unstructured":"Ryan TP, Fisher SG, Elder JL, et al. Increased cardiovascular risk associated with reduced kidney function. Am J Nephrol. 2009;29(6):620\u20135.","journal-title":"Am J Nephrol"},{"issue":"1","key":"441_CR19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1523-1755.2005.00397.x","volume":"68","author":"T Ninomiya","year":"2005","unstructured":"Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int. 2005;68(1):228\u201336.","journal-title":"Kidney Int"},{"key":"441_CR20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2369-14-152","volume":"14","author":"S Iimori","year":"2013","unstructured":"Iimori S, Noda Y, Okado T, et al. Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort study. BMC Nephrol. 2013;14:152.","journal-title":"BMC Nephrol"},{"issue":"5","key":"441_CR21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000368915","volume":"40","author":"M Rahman","year":"2014","unstructured":"Rahman M, Xie D, Feldman HI, et al. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study. Am J Nephrol. 2014;40(5):399\u2013407.","journal-title":"Am J Nephrol"},{"issue":"3","key":"441_CR22","first-page":"335","volume":"37","author":"X Jin","year":"2016","unstructured":"Jin X, Zhou J, Zhou J, Pan X, Chen H, Ge J. Role of novel risk factors in predicting risk of ischemic cardiovascular diseases in middle aged men in twenty years in Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37(3):335\u20138.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"11","key":"441_CR23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/eurheartj\/ehv724","volume":"37","author":"T Svensson","year":"2016","unstructured":"Svensson T, Inoue M, Sawada N, et al. Coping strategies and risk of cardiovascular disease incidence and mortality: the Japan Public Health Center-based prospective Study. Eur Heart J. 2016;37(11):890\u20139.","journal-title":"Eur Heart J"},{"issue":"6","key":"441_CR24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10157-010-0328-6","volume":"14","author":"E Imai","year":"2010","unstructured":"Imai E, Matsuo S, Makino H, et al. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol. 2010;14(6):558\u201370.","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"441_CR25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrneph.2013.146","volume":"9","author":"ZH Liu","year":"2013","unstructured":"Liu ZH. Nephrology in china. Nat Rev Nephrol. 2013;9(9):523\u20138.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"441_CR26","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2013.168118","volume":"310","author":"Y Xu","year":"2013","unstructured":"Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948\u201359.","journal-title":"JAMA"},{"issue":"1","key":"441_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(00)00444-7","volume":"109","author":"BF Culleton","year":"2000","unstructured":"Culleton BF, Larson MG, Parfrey PS, Kannel WB, Levy D. Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. Am J Med. 2000;109(1):1\u20138.","journal-title":"Am J Med"},{"issue":"14","key":"441_CR28","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","volume":"106","author":"HL Hillege","year":"2002","unstructured":"Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106(14):1777\u201382.","journal-title":"Circulation"},{"issue":"2","key":"441_CR29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.ajkd.2006.10.017","volume":"49","author":"J Xu","year":"2007","unstructured":"Xu J, Knowler WC, Devereux RB, et al. Albuminuria within the \u201cnormal\u201d range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. Am J Kidney Dis. 2007;49(2):208\u201316.","journal-title":"Am J Kidney Dis"},{"issue":"19","key":"441_CR30","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","volume":"288","author":"JT Wright Jr","year":"2002","unstructured":"Wright Jr JT, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288(19):2421\u201331.","journal-title":"JAMA"},{"issue":"12","key":"441_CR31","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1093\/ndt\/gfn356","volume":"23","author":"AH Brantsma","year":"2008","unstructured":"Brantsma AH, Bakker SJ, Hillege HL, De Zeeuw D, De Jong PE, Gansevoort RT. Cardiovascular and renal outcome in subjects with K\/DOQI stage 1\u20133 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant. 2008;23(12):3851\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"441_CR32","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1177\/2047487314537918","volume":"22","author":"LN Liao","year":"2015","unstructured":"Liao LN, Liu CS, Li CI, et al. Three-year incidence of elevated albuminuria and associated factors in a population-based cohort: The Taichung Community Health Study. Eur J Prev Cardiol. 2015;22(6):788\u201397.","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"441_CR33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2014.74","volume":"10","author":"B Fernandez-Fernandez","year":"2014","unstructured":"Fernandez-Fernandez B, Ortiz A, Gomez-Guerrero C, Egido J. Therapeutic approaches to diabetic nephropathy--beyond the RAS. Nat Rev Nephrol. 2014;10(6):325\u201346.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"441_CR34","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2337\/dc09-1098","volume":"33","author":"ME Molitch","year":"2010","unstructured":"Molitch ME, Steffes M, Sun W, et al. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care. 2010;33(7):1536\u201343.","journal-title":"Diabetes Care"},{"issue":"24","key":"441_CR35","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.289.24.3273","volume":"289","author":"HJ Kramer","year":"2003","unstructured":"Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289(24):3273\u20137.","journal-title":"JAMA"},{"issue":"6","key":"441_CR36","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db05-1620","volume":"55","author":"R Retnakaran","year":"2006","unstructured":"Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 2006;55(6):1832\u20139.","journal-title":"Diabetes"},{"issue":"6","key":"441_CR37","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1046\/j.1523-1755.2002.00356.x","volume":"61","author":"AX Garg","year":"2002","unstructured":"Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int. 2002;61(6):2165\u201375.","journal-title":"Kidney Int"},{"issue":"10","key":"441_CR38","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","volume":"364","author":"H Haller","year":"2011","unstructured":"Haller H, Ito S, Izzo JL, et al. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011;364(10):907\u201317.","journal-title":"N Engl J Med"},{"issue":"9638","key":"441_CR39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","volume":"372","author":"JF Mann","year":"2008","unstructured":"Mann JF, Schmieder RE, McQueen M, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet. 2008;372(9638):547\u201353.","journal-title":"Lancet"},{"issue":"9387","key":"441_CR40","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(03)14335-8","volume":"362","author":"R Beaglehole","year":"2003","unstructured":"Beaglehole R, Yach D. Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. Lancet. 2003;362(9387):903\u20138.","journal-title":"Lancet"},{"key":"441_CR41","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1111\/j.1523-1755.2005.09403.x","volume":"94","author":"RC Atkins","year":"2005","unstructured":"Atkins RC. The epidemiology of chronic kidney disease. Kidney Int Suppl. 2005;94:S14\u20138.","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"441_CR42","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1053\/ajkd.2001.29275","volume":"38","author":"A Levin","year":"2001","unstructured":"Levin A, Djurdjev O, Barrett B, et al. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis. 2001;38(6):1398\u2013407.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"441_CR43","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMc1602469","volume":"375","author":"L Zhang","year":"2016","unstructured":"Zhang L, Long J, Jiang W, et al. Trends in Chronic Kidney Disease in China. N Engl J Med. 2016;375(9):905\u20136.","journal-title":"N Engl J Med"},{"issue":"4","key":"441_CR44","first-page":"219","volume":"103","author":"FB Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez FB, Elewa U, S\u00e1nchez-Ni\u00f1o MD, et al. 2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials. Minerva Med. 2012;103(4):219\u201334.","journal-title":"Minerva Med"},{"issue":"6","key":"441_CR45","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002025","volume":"4","author":"C Wang","year":"2015","unstructured":"Wang C, Deng WJ, Gong WY, et al. High prevalence of isolated nocturnal hypertension in Chinese patients with chronic kidney disease. J Am Heart Assoc. 2015;4(6), e002025.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"441_CR46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00004872-199715040-00006","volume":"15","author":"T Ohkubo","year":"1997","unstructured":"Ohkubo T, Imai Y, Tsuji I, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens. 1997;15(4):357\u201364.","journal-title":"J Hypertens"},{"issue":"10","key":"441_CR47","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/01.CIR.0000056521.67546.AA","volume":"107","author":"K Kario","year":"2003","unstructured":"Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107(10):1401\u20136.","journal-title":"Circulation"},{"issue":"5","key":"441_CR48","first-page":"316","volume":"39","author":"YF Wu","year":"2005","unstructured":"Wu YF, Ma GS, Hu YH, et al. The current prevalence status of body overweight and obesity in China: data from the China National Nutrition and Health Survey. Zhonghua Yu Fang Yi Xue Za Zhi. 2005;39(5):316\u201320.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"4","key":"441_CR49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/j.ajkd.2005.06.007","volume":"46","author":"H Kramer","year":"2005","unstructured":"Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis. 2005;46(4):587\u201394.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"441_CR50","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1053\/j.ajkd.2005.07.040","volume":"46","author":"M Evans","year":"2005","unstructured":"Evans M, Fryzek JP, Elinder CG, et al. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis. 2005;46(5):863\u201370.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"441_CR51","doi-asserted-by":"crossref","first-page":"992","DOI":"10.2215\/CJN.04221206","volume":"2","author":"BC Kwan","year":"2007","unstructured":"Kwan BC, Murtaugh MA, Beddhu S. Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease. Clin J Am Soc Nephrol. 2007;2(5):992\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"441_CR52","volume":"7","author":"YC Chen","year":"2012","unstructured":"Chen YC, Su YC, Lee CC, Huang YS, Hwang SJ. Chronic kidney disease itself is a causal risk factor for stroke beyond traditional cardiovascular risk factors: a nationwide cohort study in Taiwan. PLoS ONE. 2012;7(4), e36332.","journal-title":"PLoS ONE"},{"issue":"8","key":"441_CR53","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1253\/circj.70.954","volume":"70","author":"K Nakamura","year":"2006","unstructured":"Nakamura K, Okamura T, Hayakawa T, et al. Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90. Circ J. 2006;70(8):954\u20139.","journal-title":"Circ J"},{"issue":"1","key":"441_CR54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2008.02.095","volume":"102","author":"NI Parikh","year":"2008","unstructured":"Parikh NI, Hwang SJ, Larson MG, Levy D, Fox CS. Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol. 2008;102(1):47\u201353.","journal-title":"Am J Cardiol"},{"issue":"10","key":"441_CR55","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehi880","volume":"27","author":"C Meisinger","year":"2006","unstructured":"Meisinger C, Doring A, Lowel H. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J. 2006;27(10):1245\u201350.","journal-title":"Eur Heart J"},{"issue":"10","key":"441_CR56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078475","volume":"8","author":"C Donfrancesco","year":"2013","unstructured":"Donfrancesco C, Palleschi S, Palmieri L, et al. Estimated glomerular filtration rate, all-cause mortality and cardiovascular diseases incidence in a low risk population: the MATISS study. PLoS ONE. 2013;8(10), e78475.","journal-title":"PLoS ONE"},{"key":"441_CR57","first-page":"957","volume":"11","author":"HD Bao","year":"2014","unstructured":"Bao HD, Sheng XH, Wang NS, et al. Analysis the Occurrence and Risk Factors of Abdominal Aorta Calcification in Advanced CKD Patients. CJITWN. 2014;11:957\u201360.","journal-title":"CJITWN"},{"issue":"6","key":"441_CR58","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/ndt\/gfp728","volume":"25","author":"S Hanada","year":"2010","unstructured":"Hanada S, Ando R, Naito S, et al. Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrol Dial Transplant. 2010;25(6):1888\u201395.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"441_CR59","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/ATVBAHA.114.303268","volume":"34","author":"MH Criqui","year":"2014","unstructured":"Criqui MH, Denenberg JO, McClelland RL, et al. Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34(7):1574\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"441_CR60","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/01.CIR.103.11.1529","volume":"103","author":"PW Wilson","year":"2001","unstructured":"Wilson PW, Kauppila LI, O\u2019Donnell CJ, et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation. 2001;103(11):1529\u201334.","journal-title":"Circulation"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0441-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T16:33:53Z","timestamp":1718987633000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0441-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,14]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["441"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0441-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,14]]},"article-number":"23"}}